Tamayo-Velasco, Á.; Martínez-Paz, P.; Peñarrubia-Ponce, M.J.; de la Fuente, I.; Pérez-González, S.; Fernández, I.; Dueñas, C.; Gómez-Sánchez, E.; Lorenzo-López, M.; Gómez-Pesquera, E.;
et al. HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients. J. Clin. Med. 2021, 10, 2017.
https://doi.org/10.3390/jcm10092017
AMA Style
Tamayo-Velasco Á, Martínez-Paz P, Peñarrubia-Ponce MJ, de la Fuente I, Pérez-González S, Fernández I, Dueñas C, Gómez-Sánchez E, Lorenzo-López M, Gómez-Pesquera E,
et al. HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients. Journal of Clinical Medicine. 2021; 10(9):2017.
https://doi.org/10.3390/jcm10092017
Chicago/Turabian Style
Tamayo-Velasco, Álvaro, Pedro Martínez-Paz, María Jesús Peñarrubia-Ponce, Ignacio de la Fuente, Sonia Pérez-González, Itziar Fernández, Carlos Dueñas, Esther Gómez-Sánchez, Mario Lorenzo-López, Estefanía Gómez-Pesquera,
and et al. 2021. "HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients" Journal of Clinical Medicine 10, no. 9: 2017.
https://doi.org/10.3390/jcm10092017
APA Style
Tamayo-Velasco, Á., Martínez-Paz, P., Peñarrubia-Ponce, M. J., de la Fuente, I., Pérez-González, S., Fernández, I., Dueñas, C., Gómez-Sánchez, E., Lorenzo-López, M., Gómez-Pesquera, E., Heredia-Rodríguez, M., Carnicero-Frutos, I., Muñoz-Moreno, M. F., Bernardo, D., Álvarez, F. J., Tamayo, E., & Gonzalo-Benito, H.
(2021). HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients. Journal of Clinical Medicine, 10(9), 2017.
https://doi.org/10.3390/jcm10092017